Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Cobcroft

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
British Journal of Haematology|February 13, 2001
Molecular remission without blood product support using all-trans retinoic acid (ATRA) induction and combined arsenic trioxide/ATRA consolidation in a Jehovah's Witness with de novo acute promyelocytic leukaemiaG A Kennedy, P Marlton, R Cobcroft, et al.
The Medical Journal of Australia|August 2, 1993
Indications for use of intravenous immunoglobulin. Recommendations of the Australasian Society of Blood Transfusion consensus symposiumT Keller, K McGrath, A Newland, et al.
Clinical and Laboratory Haematology|April 1, 2004
A simplified endogenous erythroid colony assay for the investigation of polycythaemiaS-K Tey, R Cobcroft, K Grimmett, et al.
British Journal of Haematology|January 11, 2000
Type C Niemann-Pick diseaseG A Kennedy, R Cobcroft, P Marlton, et al.
Australian and New Zealand Journal of Medicine|April 1, 1980
Current trends in the management of myasthenia gravis: plasmapheresis and immunosuppressive therapyJ D Pollard, A Basten, J E Hassall, et al.
Australian and New Zealand Journal of Medicine|August 1, 1993
Cryoglobulinaemia, hepatitis C and interferon therapyD Careless, N Sandford, R Tinniswood, et al.
Australian and New Zealand Journal of Medicine|February 1, 1986
A phase I-II study of cytosine arabinoside, daunorubicin, and VP16-213 in adult patients with acute non-lymphocytic leukemiaJ F Bishop, D E Joshua, R M Lowenthal, et al.
Leukemia & Lymphoma|September 1, 1994
The influence of induction chemotherapy dose and dose intensity on the duration of remission in acute myeloid leukemia. Australian Leukemia Study GroupJ F Bishop, J P Matthews, G Young, et al.
Blood|January 1, 1990
Etoposide in acute nonlymphocytic leukemia. Australian Leukemia Study GroupJ F Bishop, R M Lowenthal, D Joshua, et al.
Transplantation|August 5, 2000
Novel surveillance and cure of a donor-transmitted lymphoma in a renal allograft recipientK A Herzig, M C Falk, J R Jonsson, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
British Journal of Haematology|February 13, 2001
Molecular remission without blood product support using all-trans retinoic acid (ATRA) induction and combined arsenic trioxide/ATRA consolidation in a Jehovah's Witness with de novo acute promyelocytic leukaemiaG A Kennedy, P Marlton, R Cobcroft, et al.
The Medical Journal of Australia|August 2, 1993
Indications for use of intravenous immunoglobulin. Recommendations of the Australasian Society of Blood Transfusion consensus symposiumT Keller, K McGrath, A Newland, et al.
Clinical and Laboratory Haematology|April 1, 2004
A simplified endogenous erythroid colony assay for the investigation of polycythaemiaS-K Tey, R Cobcroft, K Grimmett, et al.
British Journal of Haematology|January 11, 2000
Type C Niemann-Pick diseaseG A Kennedy, R Cobcroft, P Marlton, et al.
Australian and New Zealand Journal of Medicine|April 1, 1980
Current trends in the management of myasthenia gravis: plasmapheresis and immunosuppressive therapyJ D Pollard, A Basten, J E Hassall, et al.
Australian and New Zealand Journal of Medicine|August 1, 1993
Cryoglobulinaemia, hepatitis C and interferon therapyD Careless, N Sandford, R Tinniswood, et al.
Australian and New Zealand Journal of Medicine|February 1, 1986
A phase I-II study of cytosine arabinoside, daunorubicin, and VP16-213 in adult patients with acute non-lymphocytic leukemiaJ F Bishop, D E Joshua, R M Lowenthal, et al.
Leukemia & Lymphoma|September 1, 1994
The influence of induction chemotherapy dose and dose intensity on the duration of remission in acute myeloid leukemia. Australian Leukemia Study GroupJ F Bishop, J P Matthews, G Young, et al.
Blood|January 1, 1990
Etoposide in acute nonlymphocytic leukemia. Australian Leukemia Study GroupJ F Bishop, R M Lowenthal, D Joshua, et al.
Transplantation|August 5, 2000
Novel surveillance and cure of a donor-transmitted lymphoma in a renal allograft recipientK A Herzig, M C Falk, J R Jonsson, et al.
Pageof 3